Effects of diuretics on iodine uptake in non-toxic goitre: comparison with low-iodine diet

European Journal of Nuclear Medicine - Tập 30 - Trang 1270-1272 - 2003
L. Ozlem Kapucu1,2, Fırat Azizoglu1, Goksun Ayvaz3, Ayhan Karakoc3
1Department of Nuclear Medicine, Gazi University, Ankara, Turkey
2Ankara, Turkey
3Department of Endocrinology, Gazi University, Ankara, Turkey

Tóm tắt

Low-iodine diet has been employed to achieve iodine depletion prior to radioiodine (RI) therapy. However, treatment with diuretics may be more effective than low-iodine diet in causing iodine depletion and subsequent increase in RI uptake by the thyroid. Fifty-five patients with non-toxic goitre were given 0.20 MBq RI p.o. on the first day of the study and thyroid uptake was measured. In 15 patients, a low-iodine diet was started and continued for 14 days. The remaining 40 patients received furosemide 40 mg/day orally for 5 days with an unrestricted diet. On the 15th day of the study, all patients were given 0.20 MBq RI p.o. and thyroid RI uptake was measured again. Additionally, 24-h urinary iodine excretion and RI clearance were measured on the 1st and 6th days in 21 patients from the furosemide group and on the 1st and 15th days in eight patients from the diet group. Furosemide administration led to a 58.40% increase in iodine uptake over the baseline value, which was significantly higher than the increase caused by low-iodine diet (17.22%) (P<0.0001). Urinary excretion of RI decreased in both groups similarly (furosemide, 29.45%; low-iodine diet, 21.06%; P=0.33). Iodine clearance also decreased in each group similarly (10.61% vs 7.53%, P=0.53). Treatment with furosemide prior to administration of RI increases the uptake of RI by the thyroid more effectively than does low-iodine diet.

Tài liệu tham khảo

Lakshmanan M, Schaffer A, Robbins J, Reynolds J, Norton J. A simplified low iodine diet in I-131 scanning and therapy of thyroid cancer. Clin Nucl Med 1988; 12:866–869. Ain KB, Dewitt PA, Gardner TG, Berryman SW. Low-iodine tube-feeding diet for iodine-131 scanning and therapy. Clin Nucl Med 1994; 19:504–507. Hamburger JI, Desai P. Mannitol augmentation of I-131 uptake in the treatment of thyroid carcinoma. Metabolism 1966; 15:1055–1058. Hamburger JI. Diuretic augmentation of I-131 uptake in inoperable thyroid cancer. N Engl J Med 1969; 280:1091–1094. Maruca J, Santner S, Miller KI. Prolonged iodine clearance with a depletion regimen for thyroid carcinoma: concise communication. J Nucl Med 1984; 25:1089–1093. EANM procedure guidelines for therapy with Iodine-131. Eur J Nucl Med Mol Imaging 2003; 30:BP27–BP31. Beyer KH, Fehr DM, Gelarden RT, White WJ, Lang CM, Vesell ES. Hydrochlorothiazide-induced131I excretion facilitated by salt and water. J Clin Pharmacol 1981; 21:201–212. Tepmongkol S. Enhancement of radioiodine uptake in hyperthyroidism with hydrochlorothiazide: a prospective randomised control study. Eur J Nucl Med 2002; 29:1307–1310. Jackson G. Depletion regimens for radioiodine therapy of thyroid carcinoma. J Nucl Med 1985; 26:962. Ohtaki S, Moriya S, Suzuki H, Horiuchi Y. Nonhormonal iodine escape from the normal and abnormal thyroid gland. J Clin Endocrinol 1967; 27:728–739.